Rapid Patient Testing shortens the time to clinical decision-making. It reduces turn-around time (TAT) by eliminating delays caused by transport and preparation of clinical samples, delivering improved medical outcome and lower costs.
Our comprehensive portfolio includes a wide range of clinical assays:
- Malaria
- Dengue
- Typhoid
- Covid-19
- Infectious diseases
- Rheumatology
- Pregnancy/fertility
- Drugs of abuse
- Cancer markers
- Cardiac marker
- Sickle cell anemia
All information presented is for informational purposes only and is not intended for medical advice. Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.
